(Q41658660)

6 October 2017

1 reference

title

What are the treatment goals for Helicobacter pylori infection? (English)

1 reference

6 October 2017

1 reference

Fennerty MB

1

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

113

1 reference

6 October 2017

issue

6 Suppl

1 reference

6 October 2017

page(s)

S120-5

1 reference

A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Factors influencing the eradication of Helicobacter pylori with triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

A cost analysis of alternative treatments for duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Alternative management strategies for patients with suspected peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

The economics of eradicating Helicobacter pylori infection in duodenal ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980025-X

7 January 2021

10.1016/S0016-5085(97)80025-X

Identifiers

DOI

0 references

1 reference